Congratulations to Margo Waters of the Nallathamby lab for having being selected for the Inaugural Woodward family endowment for excellence in NDnano undergraduate research! Margo has been an exceptional contributor to advancing research on novel cancer therapeutics in our lab. You can check out more about what motivates her at https://research.nd.edu/news/inaugural-woodward-family-endowment-for-excellence-in-ndnano-undergraduate-research-awarded/
Jul 02
Inaugural Woodward family endowment for excellence in NDNANO undergraduate research awarded to Margo Waters
Categories:
AD&T Notre Dame, Berthiaume Institute for Precision Health, Cancer stem cells, Combination chemotherapy, Harper Cancer Research Institute, metastatic cancer cells
by Prakash
Tags: NDNano
Recent Posts
- pdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine June 19, 2026
- AY 2026 in Review: PD[N]ano Lab Highlights Featured in the Provost’s TPAC-RL May 2026 Newsletter May 9, 2026
- Aurelie Brownsberger Leads a Student Cohort in a Journal of Nanotheranostics Invited Feature Review on Intrinsically Selective Therapeutic Nanoplatforms May 9, 2026
- Lab Family Dinner 2026: Celebrating Our Team and Sending Off Our Graduating Seniors April 28, 2026
- Pitching MagSiNs at the IDEA Center’s Inaugural Research Commercialization Grant Event April 24, 2026
Archives
Categories
NIH Funding Opportunities
- Notice of Information: Implementation of HHS Annual SBIR and STTR Application/Proposal Limit July 10, 2026Notice NOT-OD-26-090 from the NIH Guide for Grants and Contracts
- Inviting Comments and Suggestions on Topic Areas for the NIDCR Strategic Plan for Fiscal Years 2027-2031 July 8, 2026Notice NOT-DE-26-015 from the NIH Guide for Grants and Contracts
- Notice of Change: Early Expiration of Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) July 8, 2026Notice NOT-NS-26-040 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of PAR-24-252 "Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)" July 7, 2026Notice NOT-GM-26-010 from the NIH Guide for Grants and Contracts

Recent Comments